These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6810495)
1. The identification and functional significance of factor VIII components on normal platelets. Flaum MA; Donlon JA; Gralnick HR; Rick ME Thromb Res; 1982 May; 26(3):165-75. PubMed ID: 6810495 [TBL] [Abstract][Full Text] [Related]
2. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time. Aihara M; Kimura A; Chiba Y; Yoshida Y Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084 [TBL] [Abstract][Full Text] [Related]
5. Immunohistological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIIIR:Ag) in human platelet granules. Giddings JC; Brookes LR; Piovella F; Bloom AL Br J Haematol; 1982 Sep; 52(1):79-88. PubMed ID: 6810914 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein. Croissant MP; Zuzel M; Allain JP Blood; 1983 Jul; 62(1):133-40. PubMed ID: 6190519 [TBL] [Abstract][Full Text] [Related]
7. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor. Weinstein MJ; Chute LE J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875 [TBL] [Abstract][Full Text] [Related]
8. Localization of factor VIII/von Willebrand factor antigen by immunoelectron microscopy in human endothelial cells using Fab fragments coupled to peroxidase. Jeanneau C; Sultan Y J Histochem Cytochem; 1982 Nov; 30(11):1091-6. PubMed ID: 6815260 [TBL] [Abstract][Full Text] [Related]
9. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope. Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547 [TBL] [Abstract][Full Text] [Related]
10. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G. Moore A; Ross GD; Nachman RL J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473 [TBL] [Abstract][Full Text] [Related]
11. Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor. Mohri H; Noguchi T; Kodama F; Itoh A; Ohkubo T Am J Clin Pathol; 1987 May; 87(5):663-8. PubMed ID: 3107370 [TBL] [Abstract][Full Text] [Related]
12. The evaluation of factor VIII antigen by means of a simple slide test. Casonato A; Fabris F; Vicariotto M; Girolami A Am J Clin Pathol; 1985 Jul; 84(1):107-11. PubMed ID: 3925753 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Ruan C; Tobelem G; McMichael AJ; Drouet L; Legrand Y; Degos L; Kieffer N; Lee H; Caen JP Br J Haematol; 1981 Dec; 49(4):511-9. PubMed ID: 6797459 [TBL] [Abstract][Full Text] [Related]
14. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease. Green D; Potter EV J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313 [TBL] [Abstract][Full Text] [Related]
15. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin. Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011 [TBL] [Abstract][Full Text] [Related]
16. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease. Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054 [TBL] [Abstract][Full Text] [Related]
17. The mechanism of factor VIII inactivation by human antibodies. II. The effect of factor VIII R: antigen on the rate of interaction. Lazarchick J Ann Clin Lab Sci; 1985; 15(1):76-82. PubMed ID: 3918497 [TBL] [Abstract][Full Text] [Related]
18. Platelet hyperaggregability in the nephrotic syndrome which is not dependent on arachidonic acid metabolism or on plasma albumin concentration. Bennett A; Cameron JS Clin Nephrol; 1987 Apr; 27(4):182-8. PubMed ID: 3107859 [TBL] [Abstract][Full Text] [Related]
19. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
20. Fractionation of human antibody to factor VIII:C: and IRMA for phospholipid binding sites on factor VIII C:Ag. Kemball-Cook G; Barrowcliffe TW Br J Haematol; 1984 Aug; 57(4):633-6. PubMed ID: 6430335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]